Start Something, the CED Blog: CED Life Science Conference 2013 Recap

The CED Life Science Conference 2013 brought together nearly 800 entrepreneurs, investors and industry executives in the biopharma and medtech sectors.

Co-chaired by David P. King, chairman and CEO of LabCorp, Ed Mathers, partner at NEA, and Brad Wilson, president and CEO of Blue Cross and Blue Shield of North Carolina, the CED Life Science Conference 2013 focused on the changes, challenges and opportunities within the life science industry, with a particular focus on how healthcare changes as a result of the affordable care act will affect life science startups.

The CED Life Science Conference 2013 received significant media attention, and the CED team has compiled a group of articles that tell the story of the conference and summarize the conference sessions. Enjoy these summaries of the CED Life Science Conference, below.

Samuel Nussbaum, CMO of WellPoint, Inc., Opens CED Life Science Conference 2013

Samuel Nussbaum, WellPoint, Inc. CMO says big data and AI will transform health care

Samuel Nussbaum says "Best of Times, Worst of Times" confronts life science industry

Samuel Nussbuam discusses how insurers set reimbursement rates

The Annual State of the Industry Report

Deloitte exec says ACA will impact drug development

Biotech industry spawns jobs

Entrepreneur Workshop

Entrepreneur Workshop: 4 life science CEOs on lessons learned the hard way

Entrepreneur Workshop: Outrunning lions and other life science startup lessons (WRAL Tech Wire)

Bob Ingram wins Life Science Leadership Award

Hatteras' Bob Ingram wins Life Science Leadership Award, calls for more venture capital in North Carolina